May 22, 2018 Oncolytics Biotech® Has Applied to List its Common Shares on Nasdaq and Announces Share Consolidation
May 17, 2018 Oncolytics Biotech® Announces Collaboration Between Merck and Northwestern University Combining Keytruda® and REOLYSIN® in a Phase 2 Second Line Pancreatic Cancer Study
May 16, 2018 Oncolytics Biotech® Announces Publication of REOLYSIN® Abstract for the ASCO 2018 Annual Meeting
May 10, 2018 Oncolytics Biotech® Receives Special Protocol Assessment Agreement from FDA for Phase 3 Clinical Trial of Pelareorep In Metastatic Breast Cancer
May 4, 2018 Oncolytics Biotech® Announces Voting Results from its Annual General Meeting of Shareholders
Apr 18, 2018 Oncolytics Biotech(R) Demonstrates Positive Data in Two Posters at AACR Annual Meeting 2018
Apr 10, 2018 Oncolytics Biotech(R) Presents Positive REOLYSIN(R) Data in Combination with Keytruda and anti-CD73 at International Oncolytic Virus Conference 2018
